Facilitating Research, Programmatic, and Operational Support of the National Amyotrophic Lateral Sclerosis (ALS) Biorepository in support of the ALS Registry Act
Inactive on SAM.gov — responses were due 17 Sep 2026 · Small Business Set Aside - Total · Centers for Disease Control and Prevention (CDC), HHS · GA · NAICS 621991 · Solicitation 75D301-Q-26-95343
Following NAICS 621991? Get new solicitations in it by email as they post — no account needed.
A newer version of this notice has been posted. SAM.gov republished solicitation 75D301-Q-26-95343 on 14 September 2026. This page is kept because it is a real record, but the current requirement, dates and attachments are on the latest version. Read the latest version →
What happened next
SAM.gov marked this notice inactive — responses were due 17 September 2026.
No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.
Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.
This one has closed. We'll email you when new NAICS 621991 (Blood and Organ Banks) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.
Description
This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with FAR Part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. Solicitation number 75D301-26-Q-95343 is issued as a Request for Quotation for the project titled: "Facilitating Research, Programmatic, and Operational Support of the National Amyotrophic Lateral Sclerosis (ALS) Biorepository in support of the ALS Registry Act." This acquisition is set-aside for small business concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. (ii) A list of line-item number(s) and items, quantities, and units of measure can be found in the solicitation document. (iii) Description of requirements for the items to be acquired, including documentation supporting any brand name descriptions (see 12.102). See Solicitation document. (iv) Date(s) and place(s) of delivery and acceptance and f.o.b. point (see part 47). Period of performance is anticipated to be 9/28/2026 - 9/27/2031, inclusive of the base period and all option periods. (v) A list of solicitation provisions that apply to the acquisition (see 12.205(a)). See solicitation document. (vi) A list of contract clauses that apply to the acquisition (see 12.205(b)). See solicitation document. (vii) The date, time, and place for receipt of offer and point of contact. Offers are due 9/17/2026 10 AM ET to uwo8@cdc.gov. (viii) Any other additional information required by 5.101(c). Questions are due 9/11/2026 5 PM ET to uwo8@cdc.gov.
Version history
SAM.gov has posted 3 notices under solicitation 75D301-Q-26-95343, oldest first.
10 September 2026 — Combined Synopsis/Solicitation (this page)
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
